Fulcrum Therapeutics, Inc.FULCNASDAQ
Loading
Year-over-year net income growth rate
Percentile
P52
Within normal range
vs 5Y Ago
-0.6x
Contraction
Streak
1 qtr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| Q4 2025 | -3.77% |
| Q3 2025 | -13.29% |
| Q2 2025 | 2.03% |
| Q1 2025 | -6.56% |
| Q4 2024 | 23.64% |
| Q3 2024 | -139.16% |
| Q2 2024 | 306.21% |
| Q1 2024 | -8.54% |
| Q4 2023 | -3.08% |
| Q3 2023 | -0.98% |
| Q2 2023 | 4.02% |
| Q1 2023 | 5.19% |
| Q4 2022 | -10.10% |
| Q3 2022 | 30.33% |
| Q2 2022 | -31.40% |
| Q1 2022 | -10.41% |
| Q4 2021 | -13.36% |
| Q3 2021 | -5.44% |
| Q2 2021 | -15.58% |
| Q1 2021 | 4.07% |
| Q4 2020 | 6.55% |
| Q3 2020 | -20.89% |
| Q2 2020 | 15.00% |
| Q1 2020 | -14.45% |
| Q4 2019 | 2.53% |
| Q3 2019 | -25.61% |
| Q2 2019 | 64.26% |
| Q1 2019 | -315.88% |
| Q4 2018 | 0.94% |
| Q3 2018 | -13.98% |
| Q2 2018 | -13.05% |
| Q1 2018 | 0.00% |